CARL - MCAP CO - Carlsmed Inc

Carlsmed Inc (CARL) specializes in the supply of personalized surgical implants, utilizing JIT logistics and digital manufacturing to optimize inventory. The business generates revenue through B2B transactions with neurosurgeons and orthopedic centers, creating products via 3D printing and AI. This price chart on the GURU.Markets platform illustrates value trends, showing a market capitalization of 0.41 as the brand implements the Aprevo platform and advances R&D for complex spinal surgeries.

Market capitalization represents the total value of equity capital, determined by multiplying the current share price by the number of outstanding shares. Investors utilize this indicator to assess business scale and verify whether an asset meets minimum safety thresholds. The history of capitalization changes allows for the tracking of the issuer's value volatility. For Carlsmed Inc (CARL), this metric reflects market confidence in 3D-printing innovations for implants. A commitment to ESG principles and the minimization of production waste create a long-term foundation for the growth of this value.